Article

COVID-19 Vaccines: Where Do We Stand at the End of 2023?

2024-01-05

Abstract excerpt

Vaccine development against SARS-CoV-2 has been highly successful in slowing down the COVID-19 pandemic. A wide spectrum of approaches including vaccines based on whole viruses, protein subunits and peptides, viral vectors, and nucleic acids have been developed in parallel. For all types of COVID-19 vaccines, good safety and efficacy have been obtained in both preclinical animal studies and in clinical trials in h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 69165df9-6030-5c5f-8cfc-648437f6fbc1
DOI: 10.20944/preprints202401.0471.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

COVID-19 Vaccines: Where Do We Stand at the End of 2023?DOI 10.20944/preprints202401.0471.v1Read

Vaccines platforms and COVID-19: what you need to knowSemantic proximity Read

SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.Semantic proximity Read

An Overview of Vaccine Development for COVID-19Semantic proximity Read

A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and diseaseSemantic proximity Read

Translational Virology - COVID-19, The Perfect ExampleSemantic proximity Read

COVID-19 vaccinations: The unknowns, challenges, and hopes.Semantic proximity Read

Effectiveness of COVID‑19 vaccines and their challenges (Review)Semantic proximity Read

COVID-19 and COVID-19 Vaccine in Japan—A Review from a General Physician's PerspectiveSemantic proximity Read

Essential Considerations During Vaccine Design against COVID-19 and Review of Pioneering Vaccine Candidate PlatformsSemantic proximity Read

Effectiveness of the WHO-authorized Covid-19 Vaccines: a Rapid Review of Global Reports till June 30, 2021Semantic proximity Read

A review of leading COVID-19 vaccines, the quest for immune protection, and its key challenges. Part 3: Covid-19 vaccines – Key challenges and translational scienceSemantic proximity Read

Covid-19: virology, variants, and vaccinesSemantic proximity Read